| Literature DB >> 35717159 |
Claudia Der-Martirosian1,2, Karen Chu3, W Neil Steers3, Tamar Wyte-Lake3, Michelle D Balut3, Aram Dobalian3,4, Leonie Heyworth5,6, Neil M Paige7, Lucinda Leung8,9.
Abstract
BACKGROUND: At the onset of COVID-19, there was a rapid expansion of telehealth (video/telephone) visits to maintain delivery of primary care (PC) services at the Veterans Health Administration (VA). This study examines patient, provider, and site-level characteristics of any virtual and video-based care in PC.Entities:
Keywords: Primary Care; Telehealth; US Veterans Health Admininstration; Veterans; Video-Based Care
Mesh:
Year: 2022 PMID: 35717159 PMCID: PMC9206131 DOI: 10.1186/s12875-022-01738-3
Source DB: PubMed Journal: BMC Prim Care ISSN: 2731-4553
Patient characteristics at the VA Greater Los Angeles Primary Care Clinics, 12-months before (March 1, 2019-February 28, 2020) and 12-months after onset of COVID-19 (March 1, 2020-February 28, 2021)
| Patient Characteristics | 12-months before onset of COVID-19 ( | 12-months after onset of COVID-19 ( |
|---|---|---|
| Used Telehealth Services (phone or video) | 13.9% | 63.1% |
| Video Only | 0.3% | 11.3% |
| Male | 91.4% | 91.5% |
| Race: | ||
| Non-Hispanic White | 42.9% | 43.1% |
| Non-Hispanic African American | 20.9% | 21.2% |
| Hispanic | 17.7% | 17.8% |
| Non-Hispanic Other | 6.1% | 5.9% |
| Unknown | 12.5% | 12.2% |
| Age Categories: | ||
| 18–44 | 23.1% | 19.9% |
| 45–64 | 27.6% | 28.1% |
| 65–74 | 28.9% | 31.2% |
| 75+ | 20.4% | 20.8% |
| Married | 40.3% | 40.3% |
| Other Health Insurance | 43.6% | 46.0% |
| Main Medical Facility | 24.0% | 25.5% |
| Mean Age | 60.5 (SD = 17.6) | 61.7 (SD = 16.8) |
| Mean Nososa | 1.04 (SD = 1.40) ( | 1.08 (SD = 1.41) ( |
aNosos is an indicator of comorbidities and health risk (see U.S. Department of Veterans Affairs. Risk Adjustment. 2016 Mar 16 [cited 2021 June 11]. Available from: http://vaww.herc.research.va.gov/include/page.asp?id=risk-adjustment#goes-into-nosos
Fig. 1a For any virtual/telehealth (TH) use, in the pre-COVID segment, there was evidence of a slight increasing monthly trend in telehealth use. At the onset of COVID-19 (month 13, March 2020), rate of any telehealth use showed a highly significant, near-threefold increase of 28 percentage points (p < .001), and use showed significant monthly increases until the reauthorization of in-person services (month 16, June 2020). Rate of telehealth use then showed an immediate and significant dramatic reduction of 25 percentage points (p < .001) followed by a continued significant monthly reduction (p < .001). At the start of the 2020 flu season (month 20, November 2020), however, telehealth use showed a modest but significant increase followed by a significant monthly increase through the end of the time series. b For video-based care, however, different patterns of use emerged after the onset of COVID-19. Like telehealth use, before onset of COVID-19, there was evidence of an increasing monthly trend in video use (VVC). At the onset of COVID-19, however, there was a slight but significant decrease in video use, but this immediate reduction was followed by a sharp and highly significant increase until re-expansion of in-person services (month 16, June 2020), at which point video use had increased nearly eightfold. Video use then showed a slight immediate decrease, followed by a significant monthly increase until the start of the 2020 flu season (month 20, November 2020). Video use then showed a sharp and significant 20% decrease followed by a small but significant monthly decrease in video use until the end of the time series
Patient, provider, and site characteristics of any virtual care or video-based care use at the VA Greater Los Angeles PC Clinics
| Adjusted %a [non-reference vs. reference (ref) difference in % any virtual care or video-based care (95% Confidence Interval) and | ||||
|---|---|---|---|---|
| Study Covariates | Any Virtual Care | Video-Based Care | ||
| Age & Sex Interaction: | ||||
| 18–44 & Female (ref) | 40.6% (N/A) | NA | 20.2% (N/A) | NA |
| 18–44 & Male | 34.4% (−7.1, −5.2%) | <.001 | 15.3% (−6.0, −3.8%) | <.001 |
| 45–54 & Female (ref) | 38.7% (N/A) | NA | 17.2% (N/A) | NA |
| 45–54 & Male | 34.6% (−5.1, −3.2%) | <.001 | 10.6% (−7.6, − 5.6%) | <.001 |
| 65–74 & Female (ref) | 37.8% N/A | NA | 13.7% (N/A) | NA |
| 65–74 & Male | 34.9% (−4.5, −1.2%) | <.001 | 8.5% (−7.0, −3.5%) | <.001 |
| 75+ & Female (ref) | 36.1% (N/A) | NA | 7.2% (N/A) | NA |
| 75+ & Male | 35.4% (−3.1, 1.7%) | .555 | 7.0% (−2.0, 1.7%) | .854 |
| Race/Ethnicity: | ||||
| Non-Hispanic White (ref) | 35.3% (N/A) | NA | 11.1% (N/A) | NA |
| Non-Hispanic African American | 36.3% (0.5, 1.4%) | <.001 | 9.7% (−1.8, −1.0%) | <.001 |
| Non-Hispanic All Other | 34.7% (−1.3, 0.1%) | .100 | 11.5% (−0.3, 1.1%) | .300 |
| Hispanic | 34.4% (−1.3, − 0.4%) | <.001 | 10.2% (− 1.3, − 0.4%) | <.001 |
| Unknown | 34.6% (− 1.3, − 0.2%) | .011 | 10.2% (− 1.4, − 0.3%) | <.002 |
| Marital Status: | ||||
| Not Married (ref) | 35.0% (N/A) | 9.6% (N/A)_ | NA | |
| Married | 35.9% (0.6, 1.3%) | <.001 | 12.1% (2.1, 2.8%) | <.001 |
| Non-VA Health Insurance: | ||||
| No (ref) | 34.8% (N/A) | NA | 10.0% (N/A) | NA |
| Yes | 35.9% (0.7, 1.4%) | <.001 | 11.2% (0.9, 1.6%) | <.001 |
| Health Risk Factors (Nosos)b: | ||||
| 0.5 Nosos Value | 35.1% (34.9, 35.3%) | <.001 | 11.3% (11.1, 11.5%) | <.001 |
| 1.0 Nosos Value | 35.2% (35.0, 35.4%) | <.001 | 10.8% (10.6, 11.0%) | <.001 |
| 2.0 Nosos Value | 35.4% (35.2, 35.6%) | <.001 | 9.8% (9.5, 10.0%) | <.001 |
| PCClinician Type: | ||||
| MDs, PAs, NPs (ref) | 34.0% (N/A) | NA | 15.3% (N/A) | NA |
| LVNs, Medical Assistant (MAs) | 24.7% (−9.6, −8.9%) | <.001 | 0.2% (−15.4, −14.8%) | <.001 |
| Registered Nurse (RNs) | 39.1% (4.8, 5.5%) | <.001 | 2.2% (−13.4, − 12.8%) | <.001 |
| SWs, Pharmacists, Dietitians | 53.7% (19.1, 20.3%) | <.001 | 5.4% (− 10.3, − 9.5%) | <.001 |
| Mental Health Providers | 41.3% (4.5, 10.0%) | <.001 | 43.3% (23.6, 32.4%) | <.001 |
| Hospital-Based Clinic: | ||||
| No (e.g., community clinics) (ref) | 37.7% (N/A) | NA | 9.5% (N/A) | NA |
| Yes | 29.8% (−8.2, −7.5%) | <.001 | 13.1% (3.2, 4.0%) | <.001 |
aIndividual-level interrupted time series analysis using segmented logistic regression on repeated monthly observations over 24-months (March 1, 2019 through March 1, 2021) adjusting for patient and provider level clustering; patient sociodemographic variables, health status; provider and site characteristics
bThe association of the continuous Nosos score with telehealth (or video) use is expressed as the adjusted percentage of telehealth (or video) use obtained from a Nosos value of 2.0 (indicating comorbidities whose costs are likely to be two times as high as the national average, or “high-cost” users), and a Nosos value of 0.5 (indicating comorbidities whose costs are likely to be only half the national average, or “low-cost” users)